ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting.

December 7, 2007

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year

December 21, 1973

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment

February 2, 1996